A low voltage activated Ca2+ current found in a subset of human ventricular myocytes.

Channels
Xin ZhangXiongwen Chen

Abstract

Low voltage activated (ICa-LVA) calcium currents including Cav1.3 and T-type calcium current (ICa-T) have not been reported in adult human left ventricular myocytes (HLVMs). We tried to examine their existence and possible correlation with etiology and patient characteristics in a big number of human LVMs isolated from explanted terminally failing (F) hearts, failing hearts with left ventricular assist device (F-LVAD) and nonfailing (NF) human hearts. LVA (ICa-LVA) was determined by subtracting L-type Ca2+ current (ICa-L) recorded with the holding potential of -50 mV from total Ca2+ current recorded with the holding potential of -90 mV or -70 mV. ICa- LVA was further tested with its sensitivity to 100 µM CdCl2 and tetrodotoxin. Three HLVMs (3 of 137 FHLVMs) from 2 (N = 30 hearts) failing human hearts, of which one was idiopathic and the other was due to primary pulmonary hypertension, were found with ICa-LVA. ICa-LVA in one FHLVM was not sensitive to 100 µM CdCl2 while ICa-LVA in another two FHLVMs was not sensitive to tetrodotoxin. It peaked at the voltage of -40~-20 mV and had a time-dependent decay faster than ICa-L but slower than sodium current (INa). ICa-LVA was not found in any HLVMs from NF (75 HLVMs from 17 hearts) or ...Continue Reading

References

Aug 1, 1992·The Journal of Physiology·X Xu, P M Best
Aug 1, 1991·Journal of Molecular and Cellular Cardiology·D J BeuckelmannE Erdmann
Jun 1, 1988·Pflügers Archiv : European journal of physiology·J TytgatE Carmeliet
Dec 1, 1989·The Journal of Physiology·G Droogmans, B Nilius
Aug 5, 1998·Journal of Molecular and Cellular Cardiology·W GuoJ Toyama
Oct 25, 2000·American Journal of Physiology. Heart and Circulatory Physiology·V LeuranguerJ Nargeot
Oct 22, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Wei HanStanley Nattel
Apr 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Matteo E MangoniJoël Nargeot
Dec 25, 2003·The Journal of Physiology·Julien HeringRégis C Lambert
Mar 26, 2004·The Japanese Journal of Physiology·Noritsugu TohseYoichi Yamada
Oct 16, 2004·Journal of Neurophysiology·Diane LipscombeWeifeng Xu
Jun 28, 2005·Progress in Biophysics and Molecular Biology·Matteo E MangoniJoël Nargeot
Jun 13, 2006·Cell Calcium·Guy VassortJulio L Alvarez
Nov 18, 2006·Circulation Research·Ling LuNipavan Chiamvimonvat
Nov 9, 2007·Annual Review of Physiology·Donald M Bers
Aug 19, 2009·Circulation·Hideyuki KinoshitaKazuwa Nakao
Sep 5, 2009·Journal of Molecular and Cellular Cardiology·Kyoichi Ono, Toshihiko Iijima
Nov 19, 2009·The Journal of Clinical Investigation·Hiroyuki NakayamaJeffery D Molkentin
Jun 15, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Mingxin TangXiongwen Chen
Nov 30, 2010·Journal of Molecular and Cellular Cardiology·Xiongwen ChenSteven R Houser

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Software Mentioned

SAS
Clampex
Clampfit

Related Concepts

Related Feeds

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Cardiac Aneurysm

Aneurysm refers to a bulge of the wall or lining of a vessel commonly occurring in the blood vessels at the base of the septum or within the aorta. In the heart, it usually arises from a patch of weakened tissue in a ventricular wall, which swells into a bubble filled with blood. Discover the latest research on cardiac aneurysm here.